Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

The majority of patients who are chronically infected with hepatitis C virus (HCV) can now be successfully treated with drugs that directly target viral replication. Combination regimens of direct-acting antiviral agents (DAAs) provide rates of sustained virologic response exceeding 90%, regardless…

http://ift.tt/2rsirCQ